Names | |
---|---|
Preferred IUPAC name
Methyl (2E)-3-phenylprop-2-en-1-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | |
Other names
2,6-Dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid O5-methyl O3-[(E)-3-phenylprop-2-enyl] ester
| |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ChemSpider | |
MeSH | C048161 |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C25H24N2O6 | |
Molar mass | 448.46786 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Pranidipine is a calcium channel blocker. It is a long acting calcium channel antagonist of the dihydropyridine group.[1]
YouTube Encyclopedic
-
1/2Views:66138 309
-
Advances in Hypertension : Has the Ideal CCB Arrived webinar by Michael A Weber & Dr C Venkat Ram
-
Cardiac Drugs Quick and Dirty Summary
Transcription
References
- ^ Jin Yang; Keisuke Fukuo; Shigeto Morimoto; Tadaaki Niinobu; Toshimitsu Suhara; Toshio Ogihara (2000). "Pranidipine Enhances the Action of Nitric Oxide Released From Endothelial Cells". Hypertension. 35 (1 Pt 1): 82–85. doi:10.1161/01.hyp.35.1.82. PMID 10642279.
This page was last edited on 3 February 2024, at 22:06